structure_inline_fullcolor_rgb_12in@300ppi.png
Structure Therapeutics Announces Poster Presentations at the American Thoracic Society International Conference
May 18, 2023 16:30 ET | Structure Therapeutics Inc.
SAN FRANCISCO and SHANGHAI, China, May 18, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule...
structure_inline_fullcolor_rgb_12in@300ppi.png
Structure Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights
May 11, 2023 16:30 ET | Structure Therapeutics Inc.
Oral GLP-1 agonist GSBR-1290 advancing into Phase 2a study in type 2 diabetes and obesity Topline data from Phase 1b multiple ascending dose and Phase 2a studies of GSBR-1290 expected in second half...
structure_inline_fullcolor_rgb_12in@300ppi.png
Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
March 30, 2023 16:30 ET | Structure Therapeutics Inc.
Completed dosing of Phase 1b study of oral GLP-1 agonist GSBR-1290Topline data from Phase 1b and Phase 2a studies of GSBR-1290 expected in 2H 2023Completed $185.3 million upsized initial public...
structure_inline_fullcolor_rgb_12in@300ppi.png
Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares
February 07, 2023 16:00 ET | Structure Therapeutics Inc.
SAN FRANCISCO and SHANGHAI, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule...
structure_inline_fullcolor_rgb_12in@300ppi.png
硕迪生物宣布经增发的首次公开募股的定价
February 02, 2023 20:59 ET | Structure Therapeutics Inc.
加利福尼亚州旧金山和中国上海, Feb. 03, 2023 (GLOBE NEWSWIRE) -- 硕迪生物技术有限公司(纳斯达克股票代码:GPCR)是一家临床阶段的全球化生物制药公司,致力于口服小分子药物的创新研发以治疗代谢性和肺部疾病。今日,公司宣布其经增发的首次公开募股的定价。公司拟发行10,740,000股美国存托股票(ADS),每股ADS代表三股普通股,公开发行价格为每股ADS...
structure_inline_fullcolor_rgb_12in@300ppi.png
Structure Therapeutics Announces Pricing of Upsized Initial Public Offering
February 02, 2023 19:41 ET | Structure Therapeutics Inc.
SAN FRANCISCO and SHANGHAI, China, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small...
27573.jpg
GLOBAL INFRASTRUCTURE PARTNERS ANNOUNCES THE SALE OF LONDON CITY AIRPORT
February 26, 2016 02:00 ET | Global Infrastructure Partners
NEW YORK and LONDON, Feb. 26, 2016 (GLOBE NEWSWIRE) -- Global Infrastructure Partners (GIP), a leading independent infrastructure investor, announced today that its Fund, Global Infrastructure...
27573.jpg
GLOBAL INFRASTRUCTURE PARTNERS ANNOUNCES THE ELECTION OF SALIM SAMAHA AS A PARTNER
September 11, 2014 11:49 ET | Global Infrastructure Partners
NEW YORK, Sept. 11, 2014 (GLOBE NEWSWIRE) -- Global Infrastructure Partners (GIP), a leading independent global infrastructure investor, today announced the election of Salim Samaha as a Partner of...
27573.jpg
GLOBAL INFRASTRUCTURE PARTNERS AGREES TO PURCHASE A 25% EQUITY INTEREST IN FREEPORT LNG FOR $850 MILLION
July 14, 2014 11:20 ET | Global Infrastructure Partners
NEW YORK, July 14, 2014 (GLOBE NEWSWIRE) -- Global Infrastructure Partners (GIP), a leading, independent global infrastructure investor, announced today that its second fund, Global Infrastructure...